We are live on !
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.11B
AUM Growth
+$140M
(+4.7%)
Cap. Flow
-$15.5M
Cap. Flow % of AUM
Cap. Flow %
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
31.89%
Holding
3,618
New
197
Increased
1,211
Reduced
1,199
Closed
259
Avg Time Held
Equity + Options
3.7
years
Top 10 Avg Time Held
Equity + Options
2.1
years
Top 20 Avg Time Held
Equity + Options
2.5
years
Avg Time Held Equity only
3.7
years
Top 10 Avg Time Held Equity only
2.1
years
Top 20 Avg Time Held Equity only
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$72.4M |
| 2 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
+$18.9M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$9.7M |
| 4 |
iShares MSCI EAFE Growth ETF
EFG
|
+$3.85M |
| 5 |
Confluent
CFLT
|
+$3.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$39.5M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$19.1M |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$18.1M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$16.4M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$7.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.46% |
| 2 | Technology | 15.44% |
| 3 | Healthcare | 8.51% |
| 4 | Financials | 6.64% |
| 5 | Consumer Discretionary | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2801
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $1.66K | ﹤0.01% |
296
| – | – |
2022 Q2
4 quarters
|
|
|
PRTK
2802
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.66K | ﹤0.01% |
+750
| New | +$1.56K |
2023 Q2
0 quarters
|
|
|
XIN
2803
DELISTED
Xinyuan Real Estate
XIN
| $1.66K | ﹤0.01% |
+500
| New | +$1.78K |
2023 Q2
0 quarters
|
|
2804
Fate Therapeutics
FATE
$214M
| $1.64K | ﹤0.01% |
345
+191
| +124% | +$1.05K |
2020 Q4
10 quarters
|
|
|
CEQP
2805
DELISTED
Crestwood Equity Partners LP
CEQP
| $1.64K | ﹤0.01% |
62
| – | – |
2023 Q1
1 quarter
|
|
2806
Cass Information Systems
CASS
$700M
| $1.63K | ﹤0.01% |
42
-2
| -5% | -$79 |
2016 Q4
26 quarters
|
|
2807
Radware
RDWR
$1.14B
| $1.63K | ﹤0.01% |
84
| – | – |
2017 Q2
24 quarters
|
|
2808
DELISTED
Nikola Corporation Common Stock
NKLA
| $1.63K | ﹤0.01% |
39
-28
| -42% | -$772 |
2020 Q3
11 quarters
|
|
2809
Amplify BlueStar Israel Technology ETF
ITEQ
$102M
| $1.62K | ﹤0.01% |
+35
| New | +$1.59K |
2023 Q2
0 quarters
|
|
2810
Maravai LifeSciences
MRVI
$1.01B
| $1.62K | ﹤0.01% |
130
-907
| -87% | -$12.2K |
2022 Q3
3 quarters
|
|
2811
Abeona Therapeutics
ABEO
$253M
| $1.61K | ﹤0.01% |
400
| – | – |
2022 Q1
5 quarters
|
|
2812
Artivion
AORT
$1.06B
| $1.6K | ﹤0.01% |
93
| – | – |
2022 Q3
3 quarters
|
|
2813
Supernus Pharmaceuticals
SUPN
$2.21B
| $1.59K | ﹤0.01% |
53
| – | – |
2022 Q3
3 quarters
|
|
2814
Agenus
AGEN
$273M
| $1.59K | ﹤0.01% |
50
-8
| -14% | -$256 |
2023 Q1
1 quarter
|
|
2815
DELISTED
Adverum Biotechnologies
ADVM
| $1.59K | ﹤0.01% |
100
| – | – |
2020 Q1
13 quarters
|
|
2816
Global X MLP ETF
MLPA
$2.29B
| $1.59K | ﹤0.01% |
37
| – | – |
2019 Q3
15 quarters
|
|
2817
Stock Yards Bancorp
SYBT
$2.38B
| $1.59K | ﹤0.01% |
35
-52
| -60% | -$2.44K |
2020 Q4
10 quarters
|
|
2818
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.68B
| $1.58K | ﹤0.01% |
63
-82
| -57% | -$2.15K |
2021 Q2
8 quarters
|
|
2819
First Financial Bancorp
FFBC
$3.31B
| $1.57K | ﹤0.01% |
77
-26
| -25% | -$529 |
2020 Q2
12 quarters
|
|
2820
Amplify Junior Silver Miners ETF
SILJ
$3.32B
| $1.56K | ﹤0.01% |
166
| – | – |
2022 Q1
5 quarters
|
|
2821
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $1.55K | ﹤0.01% |
+208
| New | +$1.27K |
2023 Q2
0 quarters
|
|
2822
Gray Television
GTN
$451M
| $1.55K | ﹤0.01% |
197
+96
| +95% | +$738 |
2021 Q4
6 quarters
|
|
2823
Tactile Systems Technology
TCMD
$510M
| $1.55K | ﹤0.01% |
62
| – | – |
2023 Q1
1 quarter
|
|
2824
AFC Gamma
AFCG
$69.4M
| $1.54K | ﹤0.01% |
181
| – | – |
2022 Q3
3 quarters
|
|
|
CPE
2825
DELISTED
Callon Petroleum Company
CPE
| $1.54K | ﹤0.01% |
44
+30
| +214% | +$1K |
2022 Q3
3 quarters
|
|
Similar funds
Parallel Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Parallel Advisors held 3,618 positions worth $3.11B, up 4.7% from $2.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Parallel Advisors's Q2 2023 filing shows 197 new, 1,211 increased, 1,199 reduced and 259 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $39.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 50% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2023 buy was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K.
- Parallel Advisors added most to iShares MSCI USA Quality Factor ETF in Q2 2023, an estimated $72.4M increase.
- Parallel Advisors's biggest Q2 2023 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $39.5M.
- Parallel Advisors fully exited Cvent Holding Corp. Common Stock in Q2 2023, selling an estimated $1.62M.
- Parallel Advisors's ten largest holdings make up 32% of its $3.11B portfolio in Q2 2023.
- Parallel Advisors opened 197 new positions and closed 259 in Q2 2023.
- Parallel Advisors's portfolio value rose 4.7% quarter-over-quarter to $3.11B.
Based on Parallel Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.